rehatron™ alpha – the non-invasive induction therapy (NIIT) opens the door to new possibilities for treating a wide range of injuries and diseases
Physicians and therapists already working with rehatron™ alpha are in agreement: the promising technology used in non-invasive induction therapy possesses enormous treatment potential and is a humane, non-contact, entirely risk-free form of treatment that can be used for a huge variety of indications, thanks to its function and effect.
rehatron™ alpha has been developed after years of work based on the discoveries of major scientists from the last century, such as Nikola Tesla, George Lahkovsky, Antoine Priore and Raymond Rife. These scientists recognised that applying high-frequency energy pulses to the body in nano- and micro-second bursts could regenerate cells and cell structures, as well as eliminating viruses and bacteria. However, it was impossible to implement this knowledge properly in practice in earlier times, as the corresponding technical materials and components required to generate such high energy and ensure stable, permanent usage had not yet been developed.
It was only with the conception and development of rehatron™ alpha that it was possible to create a mature, stable, safe technology that complies with today's physiological, physical and medical knowledge and can be used on an ongoing basis in practice.
Put simply, rehatron™ alpha is an innovative medical therapy system that generates short-term energies of up to 120 million watts that can be applied to the body via a special treatment coil. The frequency generated here is 220 kilohertz and this makes rehatron™ alpha very different from traditional magnetic field devices, short-wave devices, pulsed microwaves etc. – an important point when it comes to understanding how this device works.
Granted, the common aim of all methods that use magnetic pulses and/or frequencies is to regulate or stimulate the cell membrane potential of diseased or degenerated cells; but while magnetic field therapy focuses on keeping intensity less than 10 µT (micro-tesla) as this range is below the strength of the Earth's magnetic field, the non-invasive induction therapy offered by rehatron™ alpha assumes that a cell that has a membrane potential of 80–100 mV (millivolts) when in a healthy condition can only be successfully charged with corresponding energy that is far beyond the membrane potential.
According to recent discoveries, cells also possess such a stable structure that effective transmembrane intracellular treatment requires energy emissions of the level generated by rehatron™ alpha. For example, a 12-volt battery can also only be charged by a device that has a higher voltage than 12 volts.